Sun Pharmaceutical Industries Limited

NSE: SUNPHARMA

Pharma Pharmaceuticals

₹1,900

+1.33%EOD · 19 Aug

Sun Pharmaceutical Industries Limited is a listed Pharmaceuticals company on NSE/BSE. Detailed profile data is being compiled — check BSE filings for the latest disclosures.

Market Cap

₹4.56 L Cr

52W Range

₹2047 / ₹1548

Volume

1567K

66.0% delivery

1Y Return

+15.6%

P/E Ratio

38.3

P/B Ratio

5.5

ROE

14.7%

Debt / Equity

5.52

Peers in Pharma

Top 8 by market cap

Company	LTP	Market Cap	P/E	P/B	ROE %	Div Yld %
Sun Pharmaceutical Industries Limited(this stock)	₹1,900	₹4.56 L Cr	38.3	5.5	14.7%	0.83%
Cipla LimitedCIPLA	₹1,422	₹1.15 L Cr	34.8	3.4	11.7%	0.89%
Lupin LimitedLUPIN	₹2,225	₹1.02 L Cr	18.5	4.5	26.9%	0.80%
Dr. Reddy's Laboratories LimitedDRREDDY	₹1,170	₹97,461 Cr	30.2	2.6	8.8%	0.66%

Technical Indicators

Full analysis · objective math, not advice

Returns

+1.3%

-1.7%

-2.1%

+6.6%

+5.9%

+15.6%

Weinstein Stage

Stage 2 — Advancing (uptrend)

RSI (14)

27 Oversold

Trend Template

5/7moderate

RS vs Nifty (3M)

+4.1pp

Moving Averages (price vs MA)

20-DMA

₹1947

below

50-DMA

₹1927

below

150-DMA

₹1826

above

200-DMA

₹1799

above

From 52W High

-7.2%

From 52W Low

+22.7%

Support (20D)

₹1868

Resistance (20D)

₹2047

Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.

Quality Signals

Multi-year consistency · Source: Screener annual data

ROE Consistency

0/0 years ≥15%

Revenue Growth

+9.0% CAGR

Up 7 of last 11 years

Earnings Quality

Fully cash-backed

OCF / Net Profit = 2.48x · 7/12 yrs +ve cash flow

Quality signals derived from multi-year annual financials. ROE consistency = years with ≥15% return on equity. Cash-backed = operating cash flow vs reported net profit (≥1x means earnings are converted to real cash, not just accruals). Educational reference only — not investment advice.

News & FilingsGoogle News + BSE

News via Google News · Not verified by IPOpulse · Not investment advice

Community discussion(0)

No comments yet — be the first to share your view.